![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Freund C.L. Clayton E.W.
Publisher: Adis International
ISSN: 1175-2203
Source: American Journal of PharmacoGenomics, Vol.3, Iss.6, 2003-01, pp. : 399-404
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Ethical considerations in clinical pharmacogenomics research
By Issa A.M.
Trends in Pharmacological Sciences, Vol. 21, Iss. 7, 2000-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Ethical and Social Issues in Pharmacogenomics Testing
Current Pharmaceutical Design, Vol. 16, Iss. 2, 2010-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Perspectives and challenges of clinical pharmacogenomics in cancer
Pharmacogenomics, Vol. 5, Iss. 5, 2004-07 ,pp. :